Document Detail


Synthesis and biological activity of uronic acid analogues of 2-5A[5'-O-triphosphoryladenylyl(2----5')adenylyl-(2'----5')adenosine].
MedLine Citation:
PMID:  1525304     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The oligonucleotide ppp5'A2'p5'A2'p5'A, known as 2-5A, is a potent translational inhibitor involved in some aspects of interferon action. To explore the specific function of the charged 5'-triphosphate moiety, we prepared a series of congeners in which the 5' region was hypermodified. Thus, uronic acid derivatives were substituted for the 5' terminal adenosine residue of 2-5A. Compounds 9, 10, 11 and 12 carried adenosine 5'-uronic acid, ethyl adenosine 5'-uronate, adenosine 5'-uronamide, and adenosine 5'-(N-ethyl)uronamide, respectively, in place of the 5' terminal adenosine triphosphate moiety of 2-5A. While all the analogues showed some weak interaction with the 2-5A-dependent endonuclease (RNase L), compound 9 showed the strongest binding ability, and while unable to activate the mouse RNase L, could activate human RNase at a concentration 100-fold greater than that required for the parent 2-5A. This result suggests that the function of the 5'(poly)phosphate moiety of 2-5A may be fulfilled by some other anionic moiety.
Authors:
J E Kinjo; A Pabuccuoglu; D K Alster; K Lesiak; P F Torrence
Related Documents :
22414424 - Deep-sea and pelagic rod visual pigments identified in the mysticete whales.
22798714 - All-trans arachidonic acid generates reactive oxygen species via xanthine dehydrogenase...
22888294 - Molecular evolution of the ent-kaurenoic acid oxidase gene in oryzeae.
22285294 - Thermolysis of microalgae and duckweed in a co(2)-swept fixed-bed reactor: bio-oil yiel...
16728954 - Estrogenic reduction of styrene monomer degraded by phanerochaete chrysosporium kfri 20...
11780054 - Carbonaceous meteorites as a source of sugar-related organic compounds for the early ea...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Drug design and discovery     Volume:  8     ISSN:  1055-9612     ISO Abbreviation:  Drug Des Discov     Publication Date:  1992 Feb 
Date Detail:
Created Date:  1992-10-19     Completed Date:  1992-10-19     Revised Date:  2011-06-17    
Medline Journal Info:
Nlm Unique ID:  9200627     Medline TA:  Drug Des Discov     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  241-54     Citation Subset:  IM    
Affiliation:
Section of Biomedical Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenine Nucleotides / chemical synthesis*,  pharmacology
Animals
Cell Line
Endoribonucleases / metabolism
Humans
Liver / drug effects,  enzymology
Lymphoid Tissue / cytology,  drug effects,  enzymology
Mice
Oligonucleotides / chemical synthesis*,  pharmacology
Oligoribonucleotides / chemical synthesis*,  pharmacology
Protein Synthesis Inhibitors / chemical synthesis*,  pharmacology
Uronic Acids / chemical synthesis*,  pharmacology
Chemical
Reg. No./Substance:
0/Adenine Nucleotides; 0/Oligonucleotides; 0/Oligoribonucleotides; 0/Protein Synthesis Inhibitors; 0/Uronic Acids; 61172-40-5/2',5'-oligoadenylate; EC 3.1.-/Endoribonucleases; EC 3.1.26.-/2-5A-dependent ribonuclease

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Iontophoretic permeability of polyethylene glycols through hairless rat skin: application of hydrody...
Next Document:  Mortality from acute respiratory infections and influenza (1976-1980)